Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset - HMS LINCS Database

Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 13 of 18
Next
>>
>
301 to 325 of 432 records
per page:

Cell line	Drug name	Experimental replicate	Timepoint	Curve type (GR values)	Curve type (relative cell counts)	Experiment name	Number of concentrations	Cell doublings (DMSO control)	GR50	GRmax	GR_AOC	GEC50	GRinf	Hill slope (GR values)	R-squared sigmoid fit (GR values)	P-value sigmoid fit (GR values)	R-squared flat fit (GR values)	IC50	Emax	AUC	EC50	Einf	Hill slope (relative cell counts)	R-squared sigmoid fit (relative cell counts)	P-value sigmoid fit (relative cell counts)	R-squared flat fit (relative cell counts)
Hs 578T	XL147	2		flat	flat	Hs578T pilaralisib 2	8	2.509	Inf	0.976	0.000255	0.0	0.976	0.01	0.435	0.181	0.997	Inf	0.97	1.0	0.0	0.97	0.01	0.432	0.183	0.996
HCC70	CAL-101	3	72	sigmoid	sigmoid	HCC70 idelalisib 0 3 72	8	2.510	Inf	0.724	0.0241	1.39	0.69	2.52	0.964	4.57e-05	NA	Inf	0.689	0.973	1.33	0.655	2.52	0.956	8.64e-05	NA
Hs 578T	Pictilisib	2		sigmoid	sigmoid	Hs578T pictilisib 2	8	2.512	1.93	0.45	0.194	0.4	0.333	0.696	0.98	8e-06	NA	1.58	0.446	0.787	0.231	0.381	0.746	0.974	1.74e-05	NA
Hs 578T	Buparlisib	2		sigmoid	sigmoid	Hs578T buparlisib 2	8	2.513	0.665	-0.42	0.251	1.61	-1.0	1.24	0.998	1.14e-08	NA	0.595	0.0445	0.779	0.595	0.0	1.36	0.994	2.48e-07	NA
Hs 578T	Alpelisib	2		flat	flat	Hs578T alpelisib 2	8	2.513	Inf	0.668	0.131	0.0	0.668	0.01	0.599	0.0647	0.856	Inf	0.634	0.847	0.0	0.634	0.01	0.541	0.0969	0.833
HCC70	PIK-93	3	72	sigmoid	sigmoid	HCC70 PIK-93 0 3 72	8	2.519	21.2	0.756	0.0663	181.0	-1.0	0.513	0.851	0.00333	NA	34.1	0.721	0.92	34.1	0.0	0.473	0.831	0.00487	NA
Hs 578T	GDC-0980	2		sigmoid	sigmoid	Hs578T apitolisib 2	8	2.520	0.176	-0.0558	0.391	0.275	-0.201	0.758	0.997	3.91e-08	NA	0.159	0.151	0.627	0.121	0.1	0.818	0.998	1.45e-08	NA
Hs 578T	Torin2	2		sigmoid	sigmoid	Hs578T Torin2 2	8	2.528	0.0153	-0.467	0.778	0.112	-0.771	0.47	0.986	2.55e-06	NA	0.0122	0.0353	0.352	0.0109	0.036	0.668	0.984	4.09e-06	NA
BT-20	Buparlisib	3	72	sigmoid	sigmoid	BT20 buparlisib 0 3 72	8	2.529	0.629	-0.303	0.26	1.06	-0.565	1.46	0.994	2.13e-07	NA	0.603	0.0696	0.764	0.603	0.0	1.52	0.984	4.36e-06	NA
Hs 578T	MK2206	2		sigmoid	sigmoid	Hs578T MK-2206 2	8	2.530	Inf	0.664	0.131	0.0699	0.752	1.34	0.75	0.0156	NA	Inf	0.628	0.848	0.0616	0.717	1.21	0.767	0.0126	NA
BT-20	PIK-93	3	72	sigmoid	sigmoid	BT20 PIK-93 0 3 72	8	2.532	2.65	0.419	0.097	7.54	-1.0	1.05	0.982	5.47e-06	NA	2.5	0.42	0.892	2.5	0.0	1.17	0.971	2.45e-05	NA
HCC70	AZD-6482	3	72	sigmoid	sigmoid	HCC70 AZD6482 0 3 72	8	2.532	1.43	0.435	0.247	0.421	0.226	0.492	0.983	4.63e-06	NA	1.13	0.431	0.729	0.208	0.286	0.5	0.982	6.2e-06	NA
Hs 578T	CAL-101	2		sigmoid	sigmoid	Hs578T idelalisib 2	8	2.534	57.5	0.801	0.0636	320.0	-0.507	0.408	0.979	9.58e-06	NA	Inf	0.766	0.923	4.27	0.505	0.495	0.975	1.65e-05	NA
Hs 578T	Sirolimus	2		flat	flat	Hs578T rapamycin 2	8	2.536	Inf	0.623	0.341	0.0	0.623	0.01	0.16	0.593	0.66	Inf	0.589	0.623	0.0	0.589	0.01	-0.232	1.0	0.624
BT-20	Trametinib	3	72	sigmoid	sigmoid	BT20 trametinib 0 3 72	8	2.539	Inf	0.64	0.208	0.104	0.541	0.392	0.967	3.69e-05	NA	Inf	0.604	0.761	0.0656	0.513	0.391	0.964	4.56e-05	NA
Hs 578T	BX-912	2		sigmoid	sigmoid	Hs578T BX-912 2	8	2.540	1.07	-0.019	0.174	1.79	-0.489	1.33	0.998	6.37e-09	NA	1.01	0.164	0.828	1.01	0.0	1.4	0.996	7.64e-08	NA
BT-20	Alpelisib	3	72	sigmoid	sigmoid	BT20 alpelisib 0 3 72	8	2.541	1.21	0.199	0.21	5.83	-1.0	0.697	0.881	0.00167	NA	1.12	0.272	0.775	1.12	0.0	0.764	0.791	0.00916	NA
Hs 578T	WYE-125132	2		sigmoid	sigmoid	Hs578T WYE-132 2	8	2.544	0.0374	0.152	0.505	0.0268	0.147	1.04	0.999	8.81e-10	NA	0.0344	0.246	0.516	0.0183	0.239	1.03	0.999	2.53e-09	NA
Hs 578T	AS605240	2		sigmoid	sigmoid	Hs578T AS-605240 2	8	2.547	1.89	0.43	0.194	1.81	0.011	0.541	0.988	1.81e-06	NA	1.6	0.426	0.784	0.971	0.117	0.532	0.983	4.67e-06	NA
HCC70	Sirolimus	3	72	sigmoid	sigmoid	HCC70 rapamycin 0 3 72	8	2.548	310.0	0.732	0.227	0.000433	0.63	0.1	0.676	0.034	NA	22876.0	0.693	0.736	0.000237	0.58	0.1	0.659	0.0397	NA
Hs 578T	Torin1	2		sigmoid	sigmoid	Hs578T Torin1 2	8	2.548	0.0205	0.144	0.566	0.0148	0.14	1.0	0.999	3.13e-10	NA	0.0182	0.241	0.463	0.00975	0.24	1.04	0.999	6.11e-10	NA
Hs 578T	Everolimus	2		sigmoid	sigmoid	Hs578T everolimus 2	8	2.550	3210000000.0	0.626	0.335	0.000205	0.476	0.1	0.791	0.00913	NA	18938.0	0.59	0.627	0.000153	0.422	0.1	0.745	0.0166	NA
Hs 578T	ZSTK474	2		sigmoid	sigmoid	Hs578T ZSTK474 2	8	2.554	0.715	0.187	0.263	5.92	-0.896	0.485	0.995	1.27e-07	NA	0.583	0.264	0.722	0.583	0.0	0.56	0.993	3.28e-07	NA
BT-20	Pictilisib	3	72	sigmoid	sigmoid	BT20 pictilisib 0 3 72	8	2.566	0.839	0.172	0.22	0.914	-0.0483	1.09	0.954	9.59e-05	NA	0.843	0.254	0.768	0.809	0.0179	0.898	0.918	0.000551	NA
BT-20	Torin1	3	72	sigmoid	sigmoid	BT20 Torin1 0 3 72	8	2.569	0.0237	0.0343	0.572	0.0199	0.0736	0.899	0.993	2.77e-07	NA	0.0208	0.184	0.46	0.0119	0.204	0.944	0.997	2.51e-08	NA

|<
<<
Previous
Page 13 of 18
Next
>>
>
301 to 325 of 432 records
per page:

HMS LINCS Project

Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)